

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of skin barrier (GO:0061436) | 6.84852089 |
| 2 | regulation of water loss via skin (GO:0033561) | 6.01446385 |
| 3 | activation of Rac GTPase activity (GO:0032863) | 6.01042893 |
| 4 | phospholipid efflux (GO:0033700) | 5.92231787 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.58358032 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.57978497 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 5.57978497 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.32884676 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 5.32884676 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 5.06731274 |
| 11 | response to peptidoglycan (GO:0032494) | 4.99028850 |
| 12 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.94101262 |
| 13 | urea metabolic process (GO:0019627) | 4.80522674 |
| 14 | urea cycle (GO:0000050) | 4.80522674 |
| 15 | high-density lipoprotein particle remodeling (GO:0034375) | 4.79396759 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 4.77913497 |
| 17 | cysteine metabolic process (GO:0006534) | 4.77033020 |
| 18 | kynurenine metabolic process (GO:0070189) | 4.75883959 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 4.68600288 |
| 20 | reverse cholesterol transport (GO:0043691) | 4.63121080 |
| 21 | indole-containing compound catabolic process (GO:0042436) | 4.62643821 |
| 22 | indolalkylamine catabolic process (GO:0046218) | 4.62643821 |
| 23 | tryptophan catabolic process (GO:0006569) | 4.62643821 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.54240641 |
| 25 | protein carboxylation (GO:0018214) | 4.54240641 |
| 26 | positive regulation of histone deacetylation (GO:0031065) | 4.53781348 |
| 27 | keratinization (GO:0031424) | 4.47739420 |
| 28 | bile acid biosynthetic process (GO:0006699) | 4.40792825 |
| 29 | tryptophan metabolic process (GO:0006568) | 4.36463778 |
| 30 | mannose metabolic process (GO:0006013) | 4.36347326 |
| 31 | hemidesmosome assembly (GO:0031581) | 4.35806422 |
| 32 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.33611142 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 4.30083168 |
| 34 | negative regulation of sterol transport (GO:0032372) | 4.29875744 |
| 35 | negative regulation of cholesterol transport (GO:0032375) | 4.29875744 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 4.29642718 |
| 37 | amino-acid betaine metabolic process (GO:0006577) | 4.28625440 |
| 38 | negative regulation of fibrinolysis (GO:0051918) | 4.24298794 |
| 39 | plasma lipoprotein particle assembly (GO:0034377) | 4.24168518 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 4.21910920 |
| 41 | imidazole-containing compound metabolic process (GO:0052803) | 4.19979085 |
| 42 | linoleic acid metabolic process (GO:0043651) | 4.18479407 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.15199338 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.15199338 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.15199338 |
| 46 | regulation of protein activation cascade (GO:2000257) | 4.09489372 |
| 47 | regulation of cholesterol homeostasis (GO:2000188) | 4.07719529 |
| 48 | glyoxylate metabolic process (GO:0046487) | 4.07211533 |
| 49 | homocysteine metabolic process (GO:0050667) | 4.01144110 |
| 50 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.99747040 |
| 51 | glycine metabolic process (GO:0006544) | 3.99406483 |
| 52 | apoptotic process involved in morphogenesis (GO:0060561) | 3.95161341 |
| 53 | regulation of fibrinolysis (GO:0051917) | 3.93828045 |
| 54 | complement activation, alternative pathway (GO:0006957) | 3.93405145 |
| 55 | atrioventricular valve morphogenesis (GO:0003181) | 3.91799750 |
| 56 | regulation of cholesterol esterification (GO:0010872) | 3.91503438 |
| 57 | bile acid metabolic process (GO:0008206) | 3.88895463 |
| 58 | phospholipid homeostasis (GO:0055091) | 3.88012411 |
| 59 | cholesterol efflux (GO:0033344) | 3.86039297 |
| 60 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.83492381 |
| 61 | lysine metabolic process (GO:0006553) | 3.83158495 |
| 62 | lysine catabolic process (GO:0006554) | 3.83158495 |
| 63 | multicellular organismal water homeostasis (GO:0050891) | 3.81805729 |
| 64 | regulation of complement activation (GO:0030449) | 3.77705057 |
| 65 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.77183325 |
| 66 | semaphorin-plexin signaling pathway (GO:0071526) | 3.75987123 |
| 67 | protein-lipid complex assembly (GO:0065005) | 3.75749693 |
| 68 | serine family amino acid metabolic process (GO:0009069) | 3.69736296 |
| 69 | glutamate metabolic process (GO:0006536) | 3.68871125 |
| 70 | alpha-amino acid catabolic process (GO:1901606) | 3.68098776 |
| 71 | bile acid and bile salt transport (GO:0015721) | 3.67865303 |
| 72 | fibrinolysis (GO:0042730) | 3.67623476 |
| 73 | acylglycerol homeostasis (GO:0055090) | 3.66146415 |
| 74 | triglyceride homeostasis (GO:0070328) | 3.66146415 |
| 75 | cell-cell junction maintenance (GO:0045217) | 3.64752613 |
| 76 | intestinal cholesterol absorption (GO:0030299) | 3.64645631 |
| 77 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.63480589 |
| 78 | plasma lipoprotein particle organization (GO:0071827) | 3.62416518 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 3.61394608 |
| 80 | aromatic amino acid family metabolic process (GO:0009072) | 3.59869319 |
| 81 | positive regulation of protein deacetylation (GO:0090312) | 3.59703527 |
| 82 | negative regulation of cell size (GO:0045792) | 3.57440650 |
| 83 | tyrosine metabolic process (GO:0006570) | 3.56491010 |
| 84 | plasma lipoprotein particle clearance (GO:0034381) | 3.56057094 |
| 85 | cellular modified amino acid catabolic process (GO:0042219) | 3.55736561 |
| 86 | carnitine metabolic process (GO:0009437) | 3.54988282 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 3.53740183 |
| 88 | cholesterol homeostasis (GO:0042632) | 3.49540736 |
| 89 | water homeostasis (GO:0030104) | 3.48000858 |
| 90 | low-density lipoprotein particle remodeling (GO:0034374) | 3.46554238 |
| 91 | sterol homeostasis (GO:0055092) | 3.42186493 |
| 92 | lipoprotein metabolic process (GO:0042157) | 3.41077972 |
| 93 | response to muramyl dipeptide (GO:0032495) | 3.39652809 |
| 94 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.39358092 |
| 95 | epithelial cell-cell adhesion (GO:0090136) | 3.39112930 |
| 96 | protein-lipid complex subunit organization (GO:0071825) | 3.38286361 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.36083750 |
| 98 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.36083750 |
| 99 | cellular amino acid catabolic process (GO:0009063) | 3.34738845 |
| 100 | positive regulation of sterol transport (GO:0032373) | 3.34543102 |
| 101 | positive regulation of cholesterol transport (GO:0032376) | 3.34543102 |
| 102 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.30668204 |
| 103 | negative regulation of viral release from host cell (GO:1902187) | 3.29616849 |
| 104 | hormone catabolic process (GO:0042447) | 3.28717436 |
| 105 | GDP-mannose metabolic process (GO:0019673) | 3.28449600 |
| 106 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.27255764 |
| 107 | interleukin-1-mediated signaling pathway (GO:0070498) | 3.25580537 |
| 108 | ethanol oxidation (GO:0006069) | 3.25020498 |
| 109 | very long-chain fatty acid metabolic process (GO:0000038) | 3.22722035 |
| 110 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.22545886 |
| 111 | negative regulation of lipase activity (GO:0060192) | 3.20430752 |
| 112 | intestinal absorption (GO:0050892) | 3.19468095 |
| 113 | glucose catabolic process (GO:0006007) | 3.19440119 |
| 114 | desmosome organization (GO:0002934) | 3.16850471 |
| 115 | drug catabolic process (GO:0042737) | 3.16523955 |
| 116 | receptor catabolic process (GO:0032801) | 3.16071457 |
| 117 | one-carbon metabolic process (GO:0006730) | 3.16026305 |
| 118 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.15655400 |
| 119 | regulation of bile acid biosynthetic process (GO:0070857) | 3.15472236 |
| 120 | citrulline biosynthetic process (GO:0019240) | 3.13869084 |
| 121 | regulation of ARF GTPase activity (GO:0032312) | 3.13556957 |
| 122 | regulation of sterol transport (GO:0032371) | 3.13382569 |
| 123 | regulation of cholesterol transport (GO:0032374) | 3.13382569 |
| 124 | glucose 6-phosphate metabolic process (GO:0051156) | 3.13225693 |
| 125 | positive regulation of cholesterol efflux (GO:0010875) | 3.12913635 |
| 126 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.12683600 |
| 127 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.11629736 |
| 128 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.06862180 |
| 129 | hepatocyte apoptotic process (GO:0097284) | 3.02041438 |
| 130 | regulation of ruffle assembly (GO:1900027) | 2.97581266 |
| 131 | positive regulation of Rac GTPase activity (GO:0032855) | 2.97470488 |
| 132 | regulation of viral release from host cell (GO:1902186) | 2.97468013 |
| 133 | cell junction maintenance (GO:0034331) | 2.96936802 |
| 134 | cellular response to virus (GO:0098586) | 2.94602201 |
| 135 | cell-substrate junction assembly (GO:0007044) | 2.91680036 |
| 136 | response to food (GO:0032094) | 2.91520261 |
| 137 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.88553343 |
| 138 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.85679615 |
| 139 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.84695966 |
| 140 | regulation of integrin activation (GO:0033623) | 2.83576054 |
| 141 | germinal center formation (GO:0002467) | 2.82762116 |
| 142 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.81063073 |
| 143 | regulation of leukocyte degranulation (GO:0043300) | 2.80362662 |
| 144 | pentose-phosphate shunt (GO:0006098) | 2.80285986 |
| 145 | neutrophil activation involved in immune response (GO:0002283) | 2.80130812 |
| 146 | cell-substrate adherens junction assembly (GO:0007045) | 2.76142302 |
| 147 | focal adhesion assembly (GO:0048041) | 2.76142302 |
| 148 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.72503485 |
| 149 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.72423031 |
| 150 | regulation of chromatin binding (GO:0035561) | 2.72073383 |
| 151 | detection of bacterium (GO:0016045) | 2.71854196 |
| 152 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.71334144 |
| 153 | amyloid precursor protein metabolic process (GO:0042982) | 2.67853272 |
| 154 | phospholipid scrambling (GO:0017121) | 2.67283141 |
| 155 | proline biosynthetic process (GO:0006561) | 2.64508918 |
| 156 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.63647298 |
| 157 | protein retention in ER lumen (GO:0006621) | 2.63315498 |
| 158 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.61896352 |
| 159 | detection of other organism (GO:0098543) | 2.61431518 |
| 160 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.60270132 |
| 161 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.59933697 |
| 162 | positive regulation of receptor recycling (GO:0001921) | 2.59216699 |
| 163 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.59197351 |
| 164 | histone H4 deacetylation (GO:0070933) | 2.58933641 |
| 165 | negative regulation of interleukin-8 production (GO:0032717) | 2.57212069 |
| 166 | snRNA metabolic process (GO:0016073) | 2.57177431 |
| 167 | myelin maintenance (GO:0043217) | 2.56577809 |
| 168 | protein kinase C signaling (GO:0070528) | 2.53175145 |
| 169 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.52871866 |
| 170 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.52827817 |
| 171 | maternal placenta development (GO:0001893) | 2.52589432 |
| 172 | striated muscle atrophy (GO:0014891) | 2.52303945 |
| 173 | citrulline metabolic process (GO:0000052) | 2.52118275 |
| 174 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.51755184 |
| 175 | osteoblast development (GO:0002076) | 2.51693239 |
| 176 | Rho protein signal transduction (GO:0007266) | 2.50088421 |
| 177 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.49796690 |
| 178 | NIK/NF-kappaB signaling (GO:0038061) | 2.49204278 |
| 179 | macrophage activation involved in immune response (GO:0002281) | 2.48522486 |
| 180 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.46558665 |
| 181 | apoptotic process involved in development (GO:1902742) | 2.45912052 |
| 182 | regulation of histone deacetylation (GO:0031063) | 2.44716648 |
| 183 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.44240634 |
| 184 | pinocytosis (GO:0006907) | 2.44169119 |
| 185 | adherens junction assembly (GO:0034333) | 2.43679582 |
| 186 | regulation of mast cell degranulation (GO:0043304) | 2.43119393 |
| 187 | establishment of apical/basal cell polarity (GO:0035089) | 2.42865576 |
| 188 | activation of JUN kinase activity (GO:0007257) | 2.42791539 |
| 189 | response to progesterone (GO:0032570) | 2.42619368 |
| 190 | protein localization to endosome (GO:0036010) | 2.42008036 |
| 191 | negative regulation of granulocyte differentiation (GO:0030853) | 2.40431648 |
| 192 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.40389230 |
| 193 | negative regulation of fatty acid transport (GO:2000192) | 2.40148467 |
| 194 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.38303962 |
| 195 | regulation of cholesterol metabolic process (GO:0090181) | 2.36860478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.17707312 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.87307765 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.64481409 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.23828851 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.43229827 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.41843498 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.86511006 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.50259583 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.34619517 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.18630941 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.02717118 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.81335952 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.80086487 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.40547198 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.35857843 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.12846057 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.94272674 |
| 18 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.87063327 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.82022902 |
| 20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.75914738 |
| 21 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.71535606 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67586455 |
| 23 | KDM2B_26808549_Chip-Seq_K562_Human | 1.65105178 |
| 24 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.63813984 |
| 25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.60057579 |
| 26 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.57535338 |
| 27 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.55858486 |
| 28 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.54802718 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54762352 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54300843 |
| 31 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.53975630 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.53673328 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.52833307 |
| 34 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.51952458 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49263564 |
| 36 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.48271095 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.47957430 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47723780 |
| 39 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.47260274 |
| 40 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.46959027 |
| 41 | MAF_26560356_Chip-Seq_TH2_Human | 1.46578645 |
| 42 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.46390333 |
| 43 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.45448666 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43059974 |
| 45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.40065695 |
| 46 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.38983653 |
| 47 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.38884816 |
| 48 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.38603001 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38191651 |
| 50 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.35595951 |
| 51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34890605 |
| 52 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.33938971 |
| 53 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.33838636 |
| 54 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.33700781 |
| 55 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.33004450 |
| 56 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31840969 |
| 57 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.31545313 |
| 58 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.30990007 |
| 59 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30876602 |
| 60 | UTX_26944678_Chip-Seq_JUKART_Human | 1.30400049 |
| 61 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29458344 |
| 62 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.26985000 |
| 63 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.26326597 |
| 64 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.26251237 |
| 65 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.24317551 |
| 66 | MYC_22102868_ChIP-Seq_BL_Human | 1.22824996 |
| 67 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21715685 |
| 68 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20587012 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20455278 |
| 70 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19257345 |
| 71 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.18482392 |
| 72 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18384260 |
| 73 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17840366 |
| 74 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.17277941 |
| 75 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17260081 |
| 76 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.17035497 |
| 77 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15605766 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15280068 |
| 79 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.15058083 |
| 80 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.14508959 |
| 81 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13357823 |
| 82 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12698643 |
| 83 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12364313 |
| 84 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12118099 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11241432 |
| 86 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10635233 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10511870 |
| 88 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.09467879 |
| 89 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.08881058 |
| 90 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.08469258 |
| 91 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.08390212 |
| 92 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07338632 |
| 93 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.07175722 |
| 94 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.07175722 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06938062 |
| 96 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.04388877 |
| 97 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.03574817 |
| 98 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.02525631 |
| 99 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02413164 |
| 100 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02286546 |
| 101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01919298 |
| 102 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.01039075 |
| 103 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00939152 |
| 104 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00785620 |
| 105 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.00490562 |
| 106 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00022109 |
| 107 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.99525438 |
| 108 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99420868 |
| 109 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99319305 |
| 110 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.99148360 |
| 111 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98230253 |
| 112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97671396 |
| 113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97511540 |
| 114 | SA1_27219007_Chip-Seq_Bcells_Human | 0.97249793 |
| 115 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96013826 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89861266 |
| 117 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89485197 |
| 118 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.89254120 |
| 119 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.88471632 |
| 120 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.88142940 |
| 121 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.88087962 |
| 122 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.87980136 |
| 123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85100863 |
| 124 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83933940 |
| 125 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83898438 |
| 126 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.82751219 |
| 127 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.82615552 |
| 128 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82268552 |
| 129 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.80520549 |
| 130 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.78670070 |
| 131 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77631393 |
| 132 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.76948946 |
| 133 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.76722985 |
| 134 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.75132488 |
| 135 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.74547939 |
| 136 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.72445754 |
| 137 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.72313451 |
| 138 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.71360062 |
| 139 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.71343709 |
| 140 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.71151942 |
| 141 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.71057571 |
| 142 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.70193633 |
| 143 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.69868971 |
| 144 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69428680 |
| 145 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.69253010 |
| 146 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.68971411 |
| 147 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.68692967 |
| 148 | P68_20966046_ChIP-Seq_HELA_Human | 0.68560932 |
| 149 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.68496426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.22423395 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.08503786 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.53537797 |
| 4 | MP0002796_impaired_skin_barrier | 4.25151192 |
| 5 | MP0005365_abnormal_bile_salt | 3.95524043 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.81027658 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 3.64777723 |
| 8 | MP0002254_reproductive_system_inflammat | 3.63888730 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.41710605 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 3.36936550 |
| 11 | MP0005083_abnormal_biliary_tract | 2.92267828 |
| 12 | MP0003941_abnormal_skin_development | 2.82754724 |
| 13 | MP0009840_abnormal_foam_cell | 2.81278882 |
| 14 | MP0005501_abnormal_skin_physiology | 2.78387509 |
| 15 | MP0005275_abnormal_skin_tensile | 2.73932624 |
| 16 | MP0003252_abnormal_bile_duct | 2.73725606 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.73291050 |
| 18 | MP0005451_abnormal_body_composition | 2.66867630 |
| 19 | MP0000566_synostosis | 2.66426258 |
| 20 | MP0000579_abnormal_nail_morphology | 2.46015684 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.35197546 |
| 22 | MP0010234_abnormal_vibrissa_follicle | 2.31267564 |
| 23 | MP0003172_abnormal_lysosome_physiology | 2.13060221 |
| 24 | MP0001666_abnormal_nutrient_absorption | 2.05560404 |
| 25 | MP0008260_abnormal_autophagy | 2.01359183 |
| 26 | MP0002060_abnormal_skin_morphology | 2.00116622 |
| 27 | MP0004947_skin_inflammation | 1.90008658 |
| 28 | MP0001216_abnormal_epidermal_layer | 1.79893547 |
| 29 | MP0000609_abnormal_liver_physiology | 1.79523807 |
| 30 | MP0005409_darkened_coat_color | 1.76099992 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.67966108 |
| 32 | MP0002877_abnormal_melanocyte_morpholog | 1.66299153 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.64651639 |
| 34 | MP0004019_abnormal_vitamin_homeostasis | 1.61743357 |
| 35 | MP0009379_abnormal_foot_pigmentation | 1.60248191 |
| 36 | MP0009278_abnormal_bone_marrow | 1.57792903 |
| 37 | MP0000678_abnormal_parathyroid_gland | 1.52358541 |
| 38 | MP0003303_peritoneal_inflammation | 1.50119838 |
| 39 | MP0004185_abnormal_adipocyte_glucose | 1.49827011 |
| 40 | MP0005332_abnormal_amino_acid | 1.48823733 |
| 41 | MP0003453_abnormal_keratinocyte_physiol | 1.47913204 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.47345605 |
| 43 | MP0002419_abnormal_innate_immunity | 1.37065809 |
| 44 | MP0000467_abnormal_esophagus_morphology | 1.37040329 |
| 45 | MP0010771_integument_phenotype | 1.33237835 |
| 46 | MP0002249_abnormal_larynx_morphology | 1.31934650 |
| 47 | MP0005025_abnormal_response_to | 1.28477312 |
| 48 | MP0003195_calcinosis | 1.22029057 |
| 49 | MP0000490_abnormal_crypts_of | 1.21256610 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.21082308 |
| 51 | MP0009931_abnormal_skin_appearance | 1.20738704 |
| 52 | MP0005076_abnormal_cell_differentiation | 1.17145967 |
| 53 | MP0001664_abnormal_digestion | 1.10458237 |
| 54 | MP0005319_abnormal_enzyme/_coenzyme | 1.09710668 |
| 55 | MP0004264_abnormal_extraembryonic_tissu | 1.09123985 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.07885017 |
| 57 | MP0001243_abnormal_dermal_layer | 1.07419095 |
| 58 | MP0004858_abnormal_nervous_system | 1.06570972 |
| 59 | MP0000377_abnormal_hair_follicle | 1.02111886 |
| 60 | MP0005310_abnormal_salivary_gland | 1.01648542 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.01270950 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 0.99618496 |
| 63 | MP0002098_abnormal_vibrissa_morphology | 0.99517646 |
| 64 | MP0003123_paternal_imprinting | 0.98096416 |
| 65 | MP0001348_abnormal_lacrimal_gland | 0.96336224 |
| 66 | MP0009764_decreased_sensitivity_to | 0.94659909 |
| 67 | MP0001764_abnormal_homeostasis | 0.91786230 |
| 68 | MP0001819_abnormal_immune_cell | 0.91224368 |
| 69 | MP0000598_abnormal_liver_morphology | 0.91101310 |
| 70 | MP0002420_abnormal_adaptive_immunity | 0.89055060 |
| 71 | MP0000685_abnormal_immune_system | 0.88888029 |
| 72 | MP0000604_amyloidosis | 0.88210378 |
| 73 | MP0005647_abnormal_sex_gland | 0.88170538 |
| 74 | MP0000470_abnormal_stomach_morphology | 0.88104821 |
| 75 | MP0000647_abnormal_sebaceous_gland | 0.86647627 |
| 76 | MP0001191_abnormal_skin_condition | 0.86465915 |
| 77 | MP0002452_abnormal_antigen_presenting | 0.85287315 |
| 78 | MP0009643_abnormal_urine_homeostasis | 0.85147162 |
| 79 | MP0001533_abnormal_skeleton_physiology | 0.84838270 |
| 80 | MP0000537_abnormal_urethra_morphology | 0.82944161 |
| 81 | MP0002723_abnormal_immune_serum | 0.82840723 |
| 82 | MP0010678_abnormal_skin_adnexa | 0.82560385 |
| 83 | MP0009053_abnormal_anal_canal | 0.82545077 |
| 84 | MP0005621_abnormal_cell_physiology | 0.81687753 |
| 85 | MP0004808_abnormal_hematopoietic_stem | 0.81261775 |
| 86 | MP0002089_abnormal_postnatal_growth/wei | 0.80405052 |
| 87 | MP0000465_gastrointestinal_hemorrhage | 0.80122631 |
| 88 | MP0003866_abnormal_defecation | 0.78591362 |
| 89 | MP0005666_abnormal_adipose_tissue | 0.78055263 |
| 90 | MP0001873_stomach_inflammation | 0.77817346 |
| 91 | MP0003878_abnormal_ear_physiology | 0.76466337 |
| 92 | MP0005377_hearing/vestibular/ear_phenot | 0.76466337 |
| 93 | MP0003183_abnormal_peptide_metabolism | 0.76186792 |
| 94 | MP0000427_abnormal_hair_cycle | 0.75841048 |
| 95 | MP0005464_abnormal_platelet_physiology | 0.75553714 |
| 96 | MP0002398_abnormal_bone_marrow | 0.75494809 |
| 97 | MP0001849_ear_inflammation | 0.74984039 |
| 98 | MP0004381_abnormal_hair_follicle | 0.73249471 |
| 99 | MP0002138_abnormal_hepatobiliary_system | 0.72973607 |
| 100 | MP0003045_fibrosis | 0.72591040 |
| 101 | MP0009763_increased_sensitivity_to | 0.72539746 |
| 102 | MP0009672_abnormal_birth_weight | 0.72451381 |
| 103 | MP0005397_hematopoietic_system_phenotyp | 0.71973336 |
| 104 | MP0001545_abnormal_hematopoietic_system | 0.71973336 |
| 105 | MP0002148_abnormal_hypersensitivity_rea | 0.71859045 |
| 106 | MP0000477_abnormal_intestine_morphology | 0.71751783 |
| 107 | MP0005000_abnormal_immune_tolerance | 0.71648426 |
| 108 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71068918 |
| 109 | MP0002405_respiratory_system_inflammati | 0.71004775 |
| 110 | MP0002429_abnormal_blood_cell | 0.70806077 |
| 111 | MP0001835_abnormal_antigen_presentation | 0.70441709 |
| 112 | MP0001765_abnormal_ion_homeostasis | 0.70402046 |
| 113 | MP0005670_abnormal_white_adipose | 0.70122228 |
| 114 | MP0000716_abnormal_immune_system | 0.70057599 |
| 115 | MP0001800_abnormal_humoral_immune | 0.69628332 |
| 116 | MP0001845_abnormal_inflammatory_respons | 0.69542716 |
| 117 | MP0003091_abnormal_cell_migration | 0.69344690 |
| 118 | MP0002998_abnormal_bone_remodeling | 0.69215230 |
| 119 | MP0005023_abnormal_wound_healing | 0.68038712 |
| 120 | MP0003436_decreased_susceptibility_to | 0.67902306 |
| 121 | MP0002086_abnormal_extraembryonic_tissu | 0.66733181 |
| 122 | MP0000367_abnormal_coat/_hair | 0.66410900 |
| 123 | MP0008961_abnormal_basal_metabolism | 0.65831387 |
| 124 | MP0002971_abnormal_brown_adipose | 0.65094466 |
| 125 | MP0003828_pulmonary_edema | 0.64804212 |
| 126 | MP0005375_adipose_tissue_phenotype | 0.64217510 |
| 127 | MP0004782_abnormal_surfactant_physiolog | 0.64159343 |
| 128 | MP0003300_gastrointestinal_ulcer | 0.63214472 |
| 129 | MP0002132_abnormal_respiratory_system | 0.61835359 |
| 130 | MP0001853_heart_inflammation | 0.61717822 |
| 131 | MP0003868_abnormal_feces_composition | 0.61006886 |
| 132 | MP0010307_abnormal_tumor_latency | 0.56274112 |
| 133 | MP0000383_abnormal_hair_follicle | 0.55814995 |
| 134 | MP0005334_abnormal_fat_pad | 0.54337369 |
| 135 | MP0004130_abnormal_muscle_cell | 0.52316317 |
| 136 | MP0008438_abnormal_cutaneous_collagen | 0.52096129 |
| 137 | MP0008469_abnormal_protein_level | 0.51543873 |
| 138 | MP0003186_abnormal_redox_activity | 0.51484133 |
| 139 | MP0001346_abnormal_lacrimal_gland | 0.50213147 |
| 140 | MP0000762_abnormal_tongue_morphology | 0.50111549 |
| 141 | MP0003950_abnormal_plasma_membrane | 0.48710078 |
| 142 | MP0009642_abnormal_blood_homeostasis | 0.47147715 |
| 143 | MP0009765_abnormal_xenobiotic_induced | 0.47096136 |
| 144 | MP0001915_intracranial_hemorrhage | 0.46111175 |
| 145 | MP0002136_abnormal_kidney_physiology | 0.45733174 |
| 146 | MP0000858_altered_metastatic_potential | 0.45521380 |
| 147 | MP0009384_cardiac_valve_regurgitation | 0.44776079 |
| 148 | MP0005636_abnormal_mineral_homeostasis | 0.43327079 |
| 149 | MP0005266_abnormal_metabolism | 0.43010405 |
| 150 | MP0010155_abnormal_intestine_physiology | 0.42763282 |
| 151 | MP0009115_abnormal_fat_cell | 0.42217529 |
| 152 | MP0002697_abnormal_eye_size | 0.41933584 |
| 153 | MP0000003_abnormal_adipose_tissue | 0.41421893 |
| 154 | MP0005376_homeostasis/metabolism_phenot | 0.40294056 |
| 155 | MP0002970_abnormal_white_adipose | 0.39236957 |
| 156 | MP0005174_abnormal_tail_pigmentation | 0.38754916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.97009722 |
| 2 | Xanthomatosis (HP:0000991) | 5.44204279 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.41788158 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.38439453 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.83782170 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.48331362 |
| 7 | Hypoalphalipoproteinemia (HP:0003233) | 4.37655811 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.29091291 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.25740633 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.18626606 |
| 11 | Abnormality of nail color (HP:0100643) | 4.12749555 |
| 12 | Myocardial infarction (HP:0001658) | 4.04114501 |
| 13 | Distal lower limb amyotrophy (HP:0008944) | 3.91760064 |
| 14 | Gangrene (HP:0100758) | 3.83661375 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.74320150 |
| 16 | Increased IgE level (HP:0003212) | 3.73208465 |
| 17 | Broad face (HP:0000283) | 3.69533808 |
| 18 | Epidermoid cyst (HP:0200040) | 3.68398934 |
| 19 | Complement deficiency (HP:0004431) | 3.62864113 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.58038468 |
| 21 | Eczematoid dermatitis (HP:0000976) | 3.47355609 |
| 22 | Thin bony cortex (HP:0002753) | 3.45782726 |
| 23 | Hyperammonemia (HP:0001987) | 3.43018787 |
| 24 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.41686313 |
| 25 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.41157053 |
| 26 | Upper limb amyotrophy (HP:0009129) | 3.36076869 |
| 27 | Distal upper limb amyotrophy (HP:0007149) | 3.36076869 |
| 28 | Joint hemorrhage (HP:0005261) | 3.32889035 |
| 29 | Hyperglycinuria (HP:0003108) | 3.28891406 |
| 30 | Easy fatigability (HP:0003388) | 3.28433835 |
| 31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.18956877 |
| 32 | Plantar hyperkeratosis (HP:0007556) | 3.17249559 |
| 33 | Right ventricular cardiomyopathy (HP:0011663) | 3.11655923 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.07809390 |
| 35 | J-shaped sella turcica (HP:0002680) | 3.07288505 |
| 36 | Reticulocytosis (HP:0001923) | 3.03975722 |
| 37 | Abnormality of methionine metabolism (HP:0010901) | 3.03527236 |
| 38 | Fat malabsorption (HP:0002630) | 3.00251182 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 2.99998115 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.99998115 |
| 41 | Hypotrichosis (HP:0001006) | 2.99755198 |
| 42 | Abnormality of complement system (HP:0005339) | 2.99649661 |
| 43 | Hyperglycinemia (HP:0002154) | 2.97638129 |
| 44 | Palmoplantar hyperkeratosis (HP:0000972) | 2.95380060 |
| 45 | Spastic diplegia (HP:0001264) | 2.94202680 |
| 46 | Hypoglycemic coma (HP:0001325) | 2.93282214 |
| 47 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.93033493 |
| 48 | Hypercholesterolemia (HP:0003124) | 2.87339020 |
| 49 | Ketosis (HP:0001946) | 2.86874166 |
| 50 | Hyperbilirubinemia (HP:0002904) | 2.86473328 |
| 51 | Conjugated hyperbilirubinemia (HP:0002908) | 2.83643752 |
| 52 | Palmar hyperkeratosis (HP:0010765) | 2.83229339 |
| 53 | Pseudobulbar signs (HP:0002200) | 2.81616301 |
| 54 | Hyperacusis (HP:0010780) | 2.74680135 |
| 55 | Ulnar bowing (HP:0003031) | 2.70817433 |
| 56 | Ectropion (HP:0000656) | 2.63960886 |
| 57 | Abnormality of the intrinsic pathway (HP:0010989) | 2.62809872 |
| 58 | Woolly hair (HP:0002224) | 2.60240291 |
| 59 | Onycholysis (HP:0001806) | 2.60101799 |
| 60 | Acanthocytosis (HP:0001927) | 2.57522949 |
| 61 | Vascular calcification (HP:0004934) | 2.56890602 |
| 62 | Abnormality of nucleobase metabolism (HP:0010932) | 2.55752047 |
| 63 | Cervical subluxation (HP:0003308) | 2.55470481 |
| 64 | Axonal loss (HP:0003447) | 2.52947865 |
| 65 | Obstructive sleep apnea (HP:0002870) | 2.51721140 |
| 66 | Poikilocytosis (HP:0004447) | 2.49154809 |
| 67 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.48251418 |
| 68 | Ridged nail (HP:0001807) | 2.48117487 |
| 69 | Increased cerebral lipofuscin (HP:0011813) | 2.47110663 |
| 70 | Cellulitis (HP:0100658) | 2.46983266 |
| 71 | Recurrent bacterial skin infections (HP:0005406) | 2.46470065 |
| 72 | Thick nail (HP:0001805) | 2.45476303 |
| 73 | Cheilitis (HP:0100825) | 2.44103184 |
| 74 | Increased connective tissue (HP:0009025) | 2.43592327 |
| 75 | Delayed CNS myelination (HP:0002188) | 2.43454712 |
| 76 | Pruritus (HP:0000989) | 2.41447194 |
| 77 | Focal segmental glomerulosclerosis (HP:0000097) | 2.37628731 |
| 78 | Malnutrition (HP:0004395) | 2.36703156 |
| 79 | Fragile skin (HP:0001030) | 2.36533922 |
| 80 | Flat acetabular roof (HP:0003180) | 2.35085177 |
| 81 | Hypochromic microcytic anemia (HP:0004840) | 2.34460092 |
| 82 | Alopecia of scalp (HP:0002293) | 2.34323846 |
| 83 | Cardiovascular calcification (HP:0011915) | 2.34226327 |
| 84 | Stridor (HP:0010307) | 2.33937315 |
| 85 | Lower limb amyotrophy (HP:0007210) | 2.31155314 |
| 86 | Fragile nails (HP:0001808) | 2.25232071 |
| 87 | Pustule (HP:0200039) | 2.25022924 |
| 88 | Recurrent abscess formation (HP:0002722) | 2.23042421 |
| 89 | Abnormality of the thoracic spine (HP:0100711) | 2.21683993 |
| 90 | Erythroderma (HP:0001019) | 2.21445688 |
| 91 | Hypertriglyceridemia (HP:0002155) | 2.21389016 |
| 92 | Abnormality of reticulocytes (HP:0004312) | 2.20767812 |
| 93 | Milia (HP:0001056) | 2.17045163 |
| 94 | Abnormality of macrophages (HP:0004311) | 2.16778232 |
| 95 | Hepatocellular carcinoma (HP:0001402) | 2.16643150 |
| 96 | Esophageal varix (HP:0002040) | 2.15993768 |
| 97 | Metaphyseal cupping (HP:0003021) | 2.15671300 |
| 98 | Skin nodule (HP:0200036) | 2.15477630 |
| 99 | Thoracic kyphosis (HP:0002942) | 2.15310198 |
| 100 | Lack of skin elasticity (HP:0100679) | 2.14760705 |
| 101 | Ketoacidosis (HP:0001993) | 2.13164312 |
| 102 | Abnormality of purine metabolism (HP:0004352) | 2.12784914 |
| 103 | Nail dystrophy (HP:0008404) | 2.12631145 |
| 104 | Achilles tendon contracture (HP:0001771) | 2.11192233 |
| 105 | Micronodular cirrhosis (HP:0001413) | 2.09444714 |
| 106 | Glomerulosclerosis (HP:0000096) | 2.09218173 |
| 107 | Neonatal onset (HP:0003623) | 2.06239410 |
| 108 | Obstructive lung disease (HP:0006536) | 2.05509989 |
| 109 | Chronic obstructive pulmonary disease (HP:0006510) | 2.05509989 |
| 110 | Abnormal blistering of the skin (HP:0008066) | 2.04711973 |
| 111 | Abnormality of iron homeostasis (HP:0011031) | 2.03327271 |
| 112 | Abnormal hair laboratory examination (HP:0003328) | 2.03213049 |
| 113 | Seborrheic dermatitis (HP:0001051) | 2.02708323 |
| 114 | Breast hypoplasia (HP:0003187) | 2.01794350 |
| 115 | Increased serum ferritin (HP:0003281) | 2.00022844 |
| 116 | Cholelithiasis (HP:0001081) | 1.98752662 |
| 117 | Advanced eruption of teeth (HP:0006288) | 1.98521559 |
| 118 | Erythema (HP:0010783) | 1.98253133 |
| 119 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.97769588 |
| 120 | Cerebral aneurysm (HP:0004944) | 1.97583561 |
| 121 | Slow saccadic eye movements (HP:0000514) | 1.96868362 |
| 122 | Polygenic inheritance (HP:0010982) | 1.96704743 |
| 123 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.96408916 |
| 124 | Abdominal distention (HP:0003270) | 1.96238649 |
| 125 | Pili torti (HP:0003777) | 1.94907513 |
| 126 | Trismus (HP:0000211) | 1.94788205 |
| 127 | Abnormal gallbladder morphology (HP:0012437) | 1.94098216 |
| 128 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.93865899 |
| 129 | Gingivitis (HP:0000230) | 1.93681342 |
| 130 | Diaphragmatic weakness (HP:0009113) | 1.93519591 |
| 131 | Steatorrhea (HP:0002570) | 1.91966997 |
| 132 | Late onset (HP:0003584) | 1.91361291 |
| 133 | Amelogenesis imperfecta (HP:0000705) | 1.90785131 |
| 134 | Parakeratosis (HP:0001036) | 1.90628228 |
| 135 | Difficulty climbing stairs (HP:0003551) | 1.90549942 |
| 136 | Curly hair (HP:0002212) | 1.89291613 |
| 137 | Long palpebral fissure (HP:0000637) | 1.89014097 |
| 138 | Acanthosis nigricans (HP:0000956) | 1.88880577 |
| 139 | Pathologic fracture (HP:0002756) | 1.88530173 |
| 140 | Selective tooth agenesis (HP:0001592) | 1.87808524 |
| 141 | Distal lower limb muscle weakness (HP:0009053) | 1.87567846 |
| 142 | Cholecystitis (HP:0001082) | 1.85987352 |
| 143 | Abnormal gallbladder physiology (HP:0012438) | 1.85987352 |
| 144 | Myopathic facies (HP:0002058) | 1.85616406 |
| 145 | Corneal erosion (HP:0200020) | 1.85474327 |
| 146 | Dysostosis multiplex (HP:0000943) | 1.85440011 |
| 147 | Joint stiffness (HP:0001387) | 1.84502679 |
| 148 | Increased mean platelet volume (HP:0011877) | 1.83316474 |
| 149 | Conjunctival hamartoma (HP:0100780) | 1.83205277 |
| 150 | Ureteral stenosis (HP:0000071) | 1.82687682 |
| 151 | Gingival bleeding (HP:0000225) | 1.82536965 |
| 152 | Squamous cell carcinoma (HP:0002860) | 1.81287972 |
| 153 | Recurrent skin infections (HP:0001581) | 1.81261917 |
| 154 | Hemorrhage of the eye (HP:0011885) | 1.81124895 |
| 155 | Mucopolysacchariduria (HP:0008155) | 1.81015114 |
| 156 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81015114 |
| 157 | Septate vagina (HP:0001153) | 1.80752476 |
| 158 | Abnormality of the Achilles tendon (HP:0005109) | 1.80185710 |
| 159 | Poikiloderma (HP:0001029) | 1.80101488 |
| 160 | Abnormality of the fingertips (HP:0001211) | 1.79391223 |
| 161 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79311379 |
| 162 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79311379 |
| 163 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79311379 |
| 164 | Upper motor neuron abnormality (HP:0002127) | 1.78675937 |
| 165 | Thrombophlebitis (HP:0004418) | 1.78601143 |
| 166 | Bulbar palsy (HP:0001283) | 1.78471068 |
| 167 | Dehydration (HP:0001944) | 1.78339725 |
| 168 | Rickets (HP:0002748) | 1.78193087 |
| 169 | Onion bulb formation (HP:0003383) | 1.77530250 |
| 170 | Hypertensive crisis (HP:0100735) | 1.76888860 |
| 171 | Premature loss of primary teeth (HP:0006323) | 1.75702142 |
| 172 | Annular pancreas (HP:0001734) | 1.73830468 |
| 173 | Progressive sensorineural hearing impairment (HP:0000408) | 1.73415546 |
| 174 | Short nail (HP:0001799) | 1.73413150 |
| 175 | Gastrointestinal inflammation (HP:0004386) | 1.72849484 |
| 176 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.72112957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 3.97359663 |
| 2 | MST1R | 3.95563756 |
| 3 | PKN2 | 3.25905348 |
| 4 | TRIB3 | 3.16746389 |
| 5 | ERN1 | 3.04098669 |
| 6 | CDK12 | 3.03884243 |
| 7 | EPHA2 | 3.01976993 |
| 8 | BCKDK | 2.50101116 |
| 9 | LMTK2 | 2.39137771 |
| 10 | FLT3 | 2.36613312 |
| 11 | MAPKAPK3 | 2.34870427 |
| 12 | MAP3K10 | 2.22892154 |
| 13 | SMG1 | 2.11444883 |
| 14 | SIK1 | 2.11414569 |
| 15 | TAOK3 | 1.99810928 |
| 16 | ERBB4 | 1.99504912 |
| 17 | MET | 1.96183268 |
| 18 | PRPF4B | 1.92596481 |
| 19 | INSRR | 1.88111538 |
| 20 | BLK | 1.88038864 |
| 21 | IRAK2 | 1.74366317 |
| 22 | MAP3K11 | 1.74025454 |
| 23 | RPS6KB2 | 1.68051159 |
| 24 | IRAK3 | 1.67061119 |
| 25 | FGFR4 | 1.64450280 |
| 26 | PIM2 | 1.63225489 |
| 27 | MAP2K3 | 1.59854013 |
| 28 | MAPK11 | 1.56703511 |
| 29 | TNK2 | 1.48341153 |
| 30 | STK10 | 1.47458813 |
| 31 | LATS1 | 1.43550049 |
| 32 | MAP3K3 | 1.38003953 |
| 33 | PTK6 | 1.37812992 |
| 34 | FGFR1 | 1.35762549 |
| 35 | NME2 | 1.28754084 |
| 36 | TAOK1 | 1.27926691 |
| 37 | BRD4 | 1.27669677 |
| 38 | TTN | 1.27215836 |
| 39 | ICK | 1.25849695 |
| 40 | MAP2K2 | 1.24695300 |
| 41 | CDK6 | 1.22835267 |
| 42 | SIK2 | 1.21159192 |
| 43 | TGFBR2 | 1.16219267 |
| 44 | PIM1 | 1.12794145 |
| 45 | EPHB1 | 1.10335101 |
| 46 | RIPK4 | 1.10311549 |
| 47 | MARK2 | 1.09704101 |
| 48 | PRKD2 | 1.08447129 |
| 49 | GRK6 | 1.05954719 |
| 50 | MTOR | 1.03394928 |
| 51 | PTK2 | 0.94111439 |
| 52 | IRAK1 | 0.93947877 |
| 53 | SIK3 | 0.93302845 |
| 54 | PIK3CG | 0.93065617 |
| 55 | TYK2 | 0.92465837 |
| 56 | MAP4K1 | 0.88372300 |
| 57 | TAOK2 | 0.86213693 |
| 58 | ERBB2 | 0.85329563 |
| 59 | PRKCI | 0.84714444 |
| 60 | NEK2 | 0.83939961 |
| 61 | MAPK15 | 0.83548107 |
| 62 | MAP3K9 | 0.81735256 |
| 63 | MAP3K13 | 0.79415942 |
| 64 | PRKG2 | 0.78877089 |
| 65 | TRPM7 | 0.78181959 |
| 66 | PAK2 | 0.76033058 |
| 67 | STK4 | 0.75805784 |
| 68 | MAP3K8 | 0.75598904 |
| 69 | RIPK1 | 0.74619070 |
| 70 | ZAP70 | 0.73304511 |
| 71 | PDPK1 | 0.71565226 |
| 72 | CAMK1D | 0.71501413 |
| 73 | BMX | 0.70615622 |
| 74 | BTK | 0.70240367 |
| 75 | MAPK4 | 0.69695455 |
| 76 | JAK2 | 0.64936836 |
| 77 | CDC42BPA | 0.64515448 |
| 78 | ITK | 0.64401502 |
| 79 | MATK | 0.63986273 |
| 80 | CSK | 0.63663366 |
| 81 | CSF1R | 0.62529719 |
| 82 | STK3 | 0.62141968 |
| 83 | PRKAA2 | 0.59370648 |
| 84 | MAP3K6 | 0.58104120 |
| 85 | GSK3A | 0.57789836 |
| 86 | PRKD3 | 0.57587656 |
| 87 | RPS6KA4 | 0.57493913 |
| 88 | LRRK2 | 0.57409195 |
| 89 | MAP3K2 | 0.55690250 |
| 90 | PDGFRA | 0.54485644 |
| 91 | MAP3K7 | 0.53707807 |
| 92 | TESK1 | 0.53103570 |
| 93 | EPHB2 | 0.51654745 |
| 94 | HIPK2 | 0.50152723 |
| 95 | CDK7 | 0.50004178 |
| 96 | CDK4 | 0.49454420 |
| 97 | ARAF | 0.48411138 |
| 98 | TEC | 0.47853256 |
| 99 | NME1 | 0.47124999 |
| 100 | NEK1 | 0.47002691 |
| 101 | IKBKB | 0.46969525 |
| 102 | MAP2K6 | 0.46672896 |
| 103 | CDK8 | 0.46543366 |
| 104 | JAK3 | 0.46481903 |
| 105 | DYRK1B | 0.46377341 |
| 106 | TLK1 | 0.45616625 |
| 107 | FER | 0.45356209 |
| 108 | IKBKE | 0.44713410 |
| 109 | NTRK1 | 0.43825968 |
| 110 | PAK4 | 0.43414428 |
| 111 | DAPK2 | 0.43153115 |
| 112 | TESK2 | 0.42862483 |
| 113 | MAPK12 | 0.41328054 |
| 114 | ALK | 0.40076861 |
| 115 | MUSK | 0.40043071 |
| 116 | MAPK3 | 0.39949429 |
| 117 | DDR2 | 0.38185987 |
| 118 | IRAK4 | 0.38050201 |
| 119 | MST4 | 0.37706832 |
| 120 | RPS6KC1 | 0.37641387 |
| 121 | RPS6KL1 | 0.37641387 |
| 122 | MAP3K14 | 0.36324074 |
| 123 | FGR | 0.34346778 |
| 124 | CHUK | 0.34077345 |
| 125 | RPS6KA2 | 0.33805645 |
| 126 | MAP3K5 | 0.33600523 |
| 127 | MAPKAPK2 | 0.33295951 |
| 128 | MAP2K4 | 0.33240218 |
| 129 | TBK1 | 0.32445761 |
| 130 | AKT2 | 0.32145953 |
| 131 | MAP3K1 | 0.31315162 |
| 132 | RPS6KA6 | 0.30927351 |
| 133 | MAPK1 | 0.29444214 |
| 134 | KSR2 | 0.29374399 |
| 135 | PDK1 | 0.26421366 |
| 136 | STK38 | 0.26027154 |
| 137 | PTK2B | 0.24818559 |
| 138 | CDK9 | 0.23472709 |
| 139 | RPS6KA1 | 0.23463161 |
| 140 | WNK4 | 0.22920056 |
| 141 | MAP2K1 | 0.22545302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.94247363 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.50478975 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.18536312 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.10674177 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79565897 |
| 6 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.45863020 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.42754321 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.40279501 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.39772381 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.37316127 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.36873302 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.31660817 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20680668 |
| 14 | ABC transporters_Homo sapiens_hsa02010 | 2.03339176 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.00520010 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99383810 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.98214591 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.93687885 |
| 19 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.91542045 |
| 20 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.91309351 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.89891692 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83777683 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.82297320 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.80605986 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.77833463 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.74319597 |
| 27 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.73616006 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73061313 |
| 29 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.69874161 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.66772014 |
| 31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.64365402 |
| 32 | Sulfur relay system_Homo sapiens_hsa04122 | 1.62059871 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.59216186 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53763661 |
| 35 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.51551780 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.48864873 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.48619676 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.46694633 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44890436 |
| 40 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.44874608 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.44621616 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.41556600 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40238078 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.40213684 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.39977228 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.39676799 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.37532550 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 1.35004789 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.34432914 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.31861513 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.31790425 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31415944 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.30347410 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.29804512 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.29702991 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26943085 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24539980 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21025407 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.20324190 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17544302 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16699176 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 1.11727751 |
| 63 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.11156096 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.10515224 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09807846 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07948138 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.07542468 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.05493030 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04794473 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.03123236 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 1.02293018 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01394128 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00729715 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 1.00601631 |
| 75 | Tuberculosis_Homo sapiens_hsa05152 | 1.00424229 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97809086 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.97167983 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96349983 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95811582 |
| 80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.95443967 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95420293 |
| 82 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.94307357 |
| 83 | Shigellosis_Homo sapiens_hsa05131 | 0.94172971 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93885664 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92882146 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92333097 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.90062578 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89506052 |
| 89 | Hepatitis B_Homo sapiens_hsa05161 | 0.88195111 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.88133280 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87612208 |
| 92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.87267026 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.87226210 |
| 94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84409909 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83282650 |
| 96 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.83054833 |
| 97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80999275 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75744596 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74264038 |
| 100 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.74045743 |
| 101 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72645097 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71381001 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68631833 |
| 104 | Platelet activation_Homo sapiens_hsa04611 | 0.68539715 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67126203 |
| 106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67008834 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66922207 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66858309 |
| 109 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.66611970 |
| 110 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66555485 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65656882 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65537820 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62749997 |
| 114 | Focal adhesion_Homo sapiens_hsa04510 | 0.62628764 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.62521657 |
| 116 | Axon guidance_Homo sapiens_hsa04360 | 0.61769707 |
| 117 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.60892782 |
| 118 | Measles_Homo sapiens_hsa05162 | 0.59785984 |
| 119 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59321823 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57462378 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56923851 |
| 122 | Malaria_Homo sapiens_hsa05144 | 0.55936175 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55038767 |
| 124 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54242316 |
| 125 | Glioma_Homo sapiens_hsa05214 | 0.52099267 |
| 126 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.52085822 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51732513 |
| 128 | Base excision repair_Homo sapiens_hsa03410 | 0.51239361 |
| 129 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50958816 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.50519359 |
| 131 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48722994 |
| 132 | Pertussis_Homo sapiens_hsa05133 | 0.47961693 |
| 133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47768699 |
| 134 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46976750 |
| 135 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.45765858 |
| 136 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45206157 |
| 137 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45095519 |
| 138 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42993487 |
| 139 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40689022 |
| 140 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37709259 |
| 141 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35565049 |
| 142 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.34464120 |
| 143 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33646904 |
| 144 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29953478 |
| 145 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29876536 |
| 146 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26878774 |
| 147 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.22986201 |
| 148 | Prion diseases_Homo sapiens_hsa05020 | 0.20764494 |
| 149 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.17540979 |
| 150 | Amoebiasis_Homo sapiens_hsa05146 | 0.16224663 |
| 151 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.15666215 |
| 152 | Thyroid cancer_Homo sapiens_hsa05216 | 0.14142282 |
| 153 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12019483 |
| 154 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10261150 |
| 155 | Apoptosis_Homo sapiens_hsa04210 | 0.09907727 |
| 156 | Hepatitis C_Homo sapiens_hsa05160 | 0.09852589 |
| 157 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.07594988 |
| 158 | Other glycan degradation_Homo sapiens_hsa00511 | 0.07097576 |
| 159 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.06871511 |
| 160 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.05087883 |
| 161 | Legionellosis_Homo sapiens_hsa05134 | 0.04737761 |
| 162 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.01327068 |
| 163 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.00820500 |
| 164 | Mineral absorption_Homo sapiens_hsa04978 | -0.0178159 |
| 165 | p53 signaling pathway_Homo sapiens_hsa04115 | -0.0173841 |
| 166 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0156149 |
| 167 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0132898 |
| 168 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0050677 |

